Yang, Freddie
Hu, Xin
Anderson, Janeane N.
Vidal, Gregory A.
Stepanski, Edward
Schwartzberg, Lee S.
Graetz, Ilana
Funding for this research was provided by:
NCI (R01CA218155, R01CA218155, R01CA218155)
Article History
Received: 30 April 2025
Accepted: 21 July 2025
First Online: 28 August 2025
Declarations
:
: The authors declare no competing interests.
: Dr. Graetz received research grants from Pfizer and PRIME Education, LLC outside the submitted work. Dr. Hu received research support from the PhRMA Foundation, St. Jude Children’s Research Hospital, Pfizer, and Johnson &Johnson outside the submitted work. Dr. Anderson received research grants from Gilead Sciences, Inc. outside the submitted work. Dr. Vidal reported receiving personal fees from Roche/Genentech, Eli Lilly, Pfizer, and AstraZeneca, and research funding from Roche/Genentech, Puma, Celcuity, Merck, BMS, Eli Lilly, AstraZeneca, Gilead, GSK, Natera, Pfizer, and Eisai outside the submitted work. Dr. Schwartzberg reported receiving personal fees from Pfizer, Helsinn, AstraZeneca, Genentech, Myriad, Napo, Eli Lilly, Coherus Biosciences, Foundation Medicine, Novartis, Daiichi Sankyo, Merck, GlaxoSmithKline, Sanofi, Mirati Therapeutics, and research support from Amgen and Pfizer outside the submitted work. No other disclosures were reported.